Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20222181Phase 3Completed
Phase 3, randomised, double-blind trial in pulmonary infection, acute bronchitis, chronic bronchitis (CB) and 2 more comparing Inhaled bromhexine hydrochloride solution with Placebo (2 arms). Primary endpoint: Change from baseline in sputum character score after completion of treatment. Started Nov 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20222181.